Company: FLDDW
Filing Date: 2025-01-22
Form Type: S-4/A
Source: 0001213900-25-005202
Chunk: 47

Company: Fold Holdings, Inc.
Filing Date: 2025-01-22
Form: S-4/A
Chunk 47
---
 Therefore, buy and sell orders submitted prior to and at the opening of initial post -closingtrading of New Fold Common Stock on Nasdaq will not have the benefit of being informed by a published price range or a price at which the underwriters initially sold shares to the public, as would be the case in an underwritten initial public offering. There will be no underwriters assuming risk in connection with an initial resale of shares of New Fold Common Stock or helping to stabilize, maintain or affect the public price of New Fold Common Stock following the Closing Date. Moreover, we will not engage in, and have not and will not, directly or indirectly, request the financial advisors to engage in, any special selling efforts or stabilization or price support activities in connection with New Fold Common Stock that will be outstanding immediately following the Closing Date. All of these differences from an underwritten public offering of Fold’s securities could result in a more volatile price for New Fold Common Stock following the Closing Date. Further, we will not conduct a traditional “roadshow” with underwriters prior to the opening of initial post -closingtrading of New Fold Common Stock on Nasdaq. There can be no guarantee that any information made available in this proxy statement/prospectus and/or otherwise disclosed or filed with the SEC will have the same impact on investor education as a traditional “roadshow” conducted in connection with an 18 underwritten initial public offering. As a result, there may not be efficient or sufficient price discovery with respect to New Fold Common Stock or sufficient demand among potential investors immediately after the Closing Date, which could result in a more volatile price for New Fold Common Stock. In addition, our initial stockholders, including our Sponsor, have interests in the Business Combination that are different from or are in addition to our stockholders and that would not be present in an underwritten public offering of Fold’s securities. Such interests may have influenced our Board in making its recommendation that you vote in favor of the approval of the Business Combination Proposal and the other proposals described in this proxy statement/prospectus. These actual or potential conflicts of interest are, to the extent material, described in the section entitled “ The Business Combination — Interests of Emerald’s Directors and Officers in the Business Combination” and “ The Business Combination — Interests of Fold’s Directors and Executive Officers in the Business Combination” beginning on page 138 of this proxy statement/prospectus. Accordingly, as an investor in the Business Combination, you may be exposed to increased risk when compared to investing in a traditional underwritten initial